All human cells are coated with complex carbohydrates that act as functional molecules known to be involved in a variety of the body’s natural processes, but also disease settings – e.g., cell signaling/activation, cell trafficking and other interactions. Consequently, they have been implicated in numerous disorders ranging from cancer to inflammation to infectious disease.
At GlycoMimetics, we are applying our extensive understanding of carbohydrate biology (“glycobiology”), including knowledge of the bioactive conformations and molecular interactions of functional carbohydrates, to rationally design, develop and commercialize highly-potent, small-molecule therapeutics that selectively target molecular mechanisms known to be centrally involved in the causes and progression of various human diseases.
All of GlycoMimetics’ drug candidates have been discovered internally, leveraging the company’s specialized synthetic chemistry platform.
